IL146391A0 - Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response - Google Patents
Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory responseInfo
- Publication number
- IL146391A0 IL146391A0 IL14639100A IL14639100A IL146391A0 IL 146391 A0 IL146391 A0 IL 146391A0 IL 14639100 A IL14639100 A IL 14639100A IL 14639100 A IL14639100 A IL 14639100A IL 146391 A0 IL146391 A0 IL 146391A0
- Authority
- IL
- Israel
- Prior art keywords
- inflammatory response
- composition
- mammalian nasal
- diseases caused
- treating mammalian
- Prior art date
Links
- 230000028709 inflammatory response Effects 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000030880 Nose disease Diseases 0.000 title 1
- 208000028347 Sinus disease Diseases 0.000 title 1
- 230000001413 cellular effect Effects 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 230000006790 cellular biosynthetic process Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31216899A | 1999-05-14 | 1999-05-14 | |
| PCT/US2000/010062 WO2000069431A1 (en) | 1999-05-14 | 2000-04-14 | Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL146391A0 true IL146391A0 (en) | 2002-07-25 |
Family
ID=23210184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14639100A IL146391A0 (en) | 1999-05-14 | 2000-04-14 | Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1183022B1 (de) |
| JP (2) | JP4885362B2 (de) |
| AT (1) | ATE493124T1 (de) |
| AU (1) | AU772148B2 (de) |
| CA (1) | CA2373611C (de) |
| DE (1) | DE60045445D1 (de) |
| IL (1) | IL146391A0 (de) |
| MX (1) | MXPA01011521A (de) |
| NZ (1) | NZ515364A (de) |
| WO (1) | WO2000069431A1 (de) |
| ZA (1) | ZA200109377B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004528307A (ja) | 2001-03-15 | 2004-09-16 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | サイトカインにより媒介される炎症性状態の治療のためのピルベートおよび／またはその誘導体の使用方法 |
| WO2006003492A2 (en) * | 2004-07-02 | 2006-01-12 | Warner-Lambert Company Llc | Compositions and methods for treating pathological infections |
| CA2910825A1 (en) * | 2013-03-28 | 2014-10-02 | Pharmacaribe, Llc | Compositions, formulations and methods of bio-balancing the ph of sterile isotonic saline and hypertonic saline solutions |
| US12611389B1 (en) * | 2025-08-15 | 2026-04-28 | Cellular Sciences, Inc. | Compositions and methods to reduce or eliminate nasal biofilms and mucus barriers allowing sodium pyruvate to increase the synthesis of nitric oxide and eliminate nasal infections and their toxins that cause lung, nerve and brain damage |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478565A (en) * | 1990-03-27 | 1995-12-26 | Warner-Lambert Company | Treatment of sinus headache |
| US5240694A (en) * | 1991-09-23 | 1993-08-31 | University Of Virginia | Combined antiviral and antimediator treatment of common colds |
| AU1093195A (en) * | 1993-11-19 | 1995-06-06 | Schering-Plough Healthcare Products, Inc. | Nasal spray compositions containing oxymetazoline |
| AU719332B2 (en) * | 1995-09-19 | 2000-05-04 | Cellular Sciences, Inc. | Method and composition for treating mammalian diseases caused by inflammatory response |
| JPH101442A (ja) * | 1996-06-12 | 1998-01-06 | Taisho Pharmaceut Co Ltd | 鼻炎用点鼻薬 |
-
2000
- 2000-04-14 AT AT00925997T patent/ATE493124T1/de not_active IP Right Cessation
- 2000-04-14 CA CA002373611A patent/CA2373611C/en not_active Expired - Lifetime
- 2000-04-14 MX MXPA01011521A patent/MXPA01011521A/es active IP Right Grant
- 2000-04-14 IL IL14639100A patent/IL146391A0/xx unknown
- 2000-04-14 JP JP2000617890A patent/JP4885362B2/ja not_active Expired - Lifetime
- 2000-04-14 AU AU44602/00A patent/AU772148B2/en not_active Expired
- 2000-04-14 EP EP00925997A patent/EP1183022B1/de not_active Expired - Lifetime
- 2000-04-14 DE DE60045445T patent/DE60045445D1/de not_active Expired - Lifetime
- 2000-04-14 WO PCT/US2000/010062 patent/WO2000069431A1/en not_active Ceased
- 2000-04-14 NZ NZ515364A patent/NZ515364A/en not_active IP Right Cessation
-
2001
- 2001-11-07 ZA ZA200109377A patent/ZA200109377B/en unknown
-
2011
- 2011-06-16 JP JP2011134663A patent/JP2011190274A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATE493124T1 (de) | 2011-01-15 |
| AU772148B2 (en) | 2004-04-08 |
| JP4885362B2 (ja) | 2012-02-29 |
| JP2011190274A (ja) | 2011-09-29 |
| WO2000069431A1 (en) | 2000-11-23 |
| MXPA01011521A (es) | 2003-08-20 |
| AU4460200A (en) | 2000-12-05 |
| CA2373611C (en) | 2009-06-23 |
| NZ515364A (en) | 2004-05-28 |
| EP1183022A1 (de) | 2002-03-06 |
| EP1183022A4 (de) | 2004-12-08 |
| JP2002544228A (ja) | 2002-12-24 |
| EP1183022B1 (de) | 2010-12-29 |
| DE60045445D1 (de) | 2011-02-10 |
| CA2373611A1 (en) | 2000-11-23 |
| ZA200109377B (en) | 2002-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9703653A (es) | Composicion y metodo para tratar enfermedades mamiferas ocasionadas por la respuesta inflamatoria. | |
| HK1045306A1 (zh) | 抑制细胞黏附的抗炎化合物 | |
| CA2374003A1 (en) | Improved cellular uptake of bioactive agents | |
| BR9910864A (pt) | Compostos anti-inflamatórios para inibição de aderência celular | |
| AU2003209259A1 (en) | Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof | |
| EP1614414A3 (de) | Kupferverbindung enthaltende Zusammensetzungen zur Behandlung von Erkrankungen bei Säugetieren | |
| DK1017692T3 (da) | 4-Heteroaryl-tetrahydroquinoliner og deres anvendelse som inhibitorer af cholesterolester-transferproteiner | |
| PT1268445E (pt) | Derivados de 4-amino-5-ciano-2-anilino-pirimidina e sua utilizacao como inibidores de cinases do ciclo celular | |
| BR0112160A (pt) | Agentes antiinflamatórios seletivos para glicocorticóides | |
| NO20043038L (no) | Polymorfe former av klopidogrel-hydrogensulfat | |
| IL163180A (en) | Growing populations of renewable hematopoietic stem cells and their methods | |
| NO20022359D0 (no) | Inhibering av genekspresjon med dsRNA | |
| WO2004029281A3 (en) | Methods and compositions for rnai mediated inhibition of viral gene expression in mammals | |
| BR0116402A (pt) | Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular | |
| WO2005030120A3 (en) | Antiangiogenic agents | |
| DK1427297T3 (da) | Appetitnedsættende procyanidin-holdigt præparat til pattedyr | |
| DE60019121D1 (de) | Kaliumkanäleöffner | |
| IL152961A0 (en) | Inhibitors of alpha beta 2 mediated cell adhesion | |
| AU7548500A (en) | Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents | |
| EP1183022A4 (de) | VERFAHREN UND ZUSAMMENSETZUNG ZUR BEHANDLUNG VON ENTZüNDUNGSREAKTION BEDINGTEN NASEN- UND NEBENHöLENKRANKHEITEN IN SäUGETIEREN | |
| ITRM20010476A1 (it) | Lamine di epitelio corneale umano ricostruite e metodo per il loro ottenimento. | |
| AU2001234273A1 (en) | Thiazolopyrimidines and their use as modulators of chemokine receptor activity | |
| NZ330244A (en) | Isoxazole derivatives useful in the treatment of inflammatory diseases | |
| MY135375A (en) | Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases | |
| MXPA04007362A (es) | Reduccion del crecimiento de vello. |